BioXcel Therapeutics, Inc. Profile Avatar - Palmy Investing

BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing …

Biotechnology
US, New Haven [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of BTAI's Analysis
CIK: 1720893 CUSIP: 09075P105 ISIN: US09075P1057 LEI: - UEI: -
Secondary Listings
BTAI has no secondary listings inside our databases.